SCHEMBL30668190

SCHEMBL30668190

COc1cc(CP(=O)(O)O)cc(OC)c1C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 6/20 0.41
▸ CNR1 P21554 5/20 0.41
▸ PGK1 P00558 1/20 0.41
▸ PGK2 P07205 1/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ PTPRB P23467 1/20 0.38
▸ HTR2A P28223 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ PDE3B Q13370 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ ABCB1 P08183 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30668194 0.98 PGK1 (0.42) CNR2CNR1PGK1PGK2PTGDR2
SCHEMBL26684665 0.82 CNR2 (0.39) CNR2CNR1PTGDR2ALDH1A1KDM4E
SCHEMBL26684667 0.80 CNR2 (0.38) CNR2CNR1ALDH1A1KDM4EHTR2A
SCHEMBL26684590 0.80 CNR2 (0.46) CNR2CNR1PTGDR2ALDH1A1KDM4E
SCHEMBL26684636 0.78 CNR2 (0.45) CNR2CNR1ALDH1A1KDM4EHTR2A
SCHEMBL26684938 0.76 CNR2 (0.43) CNR2CNR1PTGDR2ALDH1A1KDM4E
SCHEMBL26685820 0.76 CNR2 (0.39) CNR2CNR1PTGDR2ALDH1A1KDM4E
SCHEMBL30038814 0.76 HTR2A (0.44) CNR2CNR1ALDH1A1KDM4EHTR2A
SCHEMBL26684865 0.74 HTR2A (0.43) CNR2CNR1ALDH1A1KDM4EHTR2A
SCHEMBL5660361 0.74 PGK1 (0.52) PGK1PGK2KDM4EPTPRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023217049-A1 STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF 南京济群医药科技股份有限公司 2023-11-16 — — WO disclosed
Send feedback